Biodesix Inc (NASDAQ:BDSX) shares, rose in value, with the stock price down by -7.28% to the previous day’s close as strong demand from buyers drove the stock to $1.40.
Actively observing the price movement in the last trading, the stock closed the session at $1.51. The value of beta (5-year monthly) was 1.13. Referring to stock’s 52-week performance, its high was $2.21, and the low was $1.03. On the whole, BDSX has fluctuated by -8.50% over the past month.
With the market capitalization of Biodesix Inc currently standing at about $135.72 million, investors are eagerly awaiting this quarter’s results, scheduled for May 09, 2024 – May 13, 2024. As a result, investors might want to see an improvement in the stock’s price before the company announces its earnings report. Analysts are projecting the company’s earnings per share (EPS) to be -$0.15, which is expected to increase to -$0.1 for fiscal year -$0.42 and then to about -$0.32 by fiscal year 2025. Data indicates that the EPS growth is expected to be 34.40% in 2025, while the next year’s EPS growth is forecast to be 23.80%.
Analysts have estimated the company’s revenue for the quarter at $14.15 million, with a low estimate of $14 million and a high estimate of $14.3 million. According to the average forecast, sales growth in current quarter could jump up 56.30%, compared to the corresponding quarter of last year. Wall Street analysts also predicted that in 2025, the company’s y-o-y revenues would reach $65.25 million, representing an increase of 32.90% from the revenues reported in the last year’s results.
Revisions could be a useful indicator to get insight on short-term price movement; so for the company, there were no upward and no downward review(s) in last seven days. We see that BDSX’s technical picture suggests that short-term indicators denote the stock is a 100% Sell on average. However, medium term indicators have put the stock in the category of Hold while long term indicators on average have been pointing out that it is a 50% Sell.
The stock’s technical analysis shows that the PEG ratio is about 0, with the price of BDSX currently trading nearly -3.35% and -13.85% away from the simple moving averages for 20 and 50 days respectively. The Relative Strength Index (RSI, 14) currently indicates a reading of 41.88, while the 7-day volatility ratio is showing 8.64% which for the 30-day chart, stands at 6.80%. Furthermore, Biodesix Inc (BDSX)’s beta value is 1.08, and its average true range (ATR) is 0.11.
A comparison of Biodesix Inc (BDSX) with its peers suggests the former has fared considerably weaker in the market. BDSX showed an intraday change of -7.28% in last session, and over the past year, it shrunk by -23.50%%.
Data on historical trading for Biodesix Inc (NASDAQ:BDSX) indicates that the trading volumes over the past 10 days have averaged 59860.0 and over the past 3 months, they’ve averaged 106.99K. According to company’s latest data on outstanding shares, there are 96.24 million shares outstanding.
Nearly 74.28% of Biodesix Inc’s shares belong to company insiders and institutional investors own 16.09% of the company’s shares. The data on short interest also indicates that stock shorts accounted for 0.18 million shares as on Mar 15, 2024, resulting in a short ratio of 2.12. According to the data, the short interest in Biodesix Inc (BDSX) stood at 0.19% of shares outstanding as of Mar 15, 2024; the number of short shares registered in Feb 15, 2024 reached 0.17 million. The stock has fallen by -23.91% since the beginning of the year, thereby showing the potential of a further growth. This could raise investors’ confidence to be optimistic about the BDSX stock heading into the next quarter.
